Free Trial

Prelude Therapeutics (PRLD) Earnings Date, Estimates & Call Transcripts

Prelude Therapeutics logo
$4.27 0.00 (0.00%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$4.26 0.00 (-0.12%)
As of 05/22/2026 07:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Prelude Therapeutics Earnings Summary

Prelude Therapeutics posted Q1 2026 earnings on May 12, 2026, reporting an EPS of -$0.13, which topped analysts' consensus estimates of -$0.27 by $0.14. Quarterly revenue was reported to be $4.58 million, below the consensus estimate of $4.58 million. With a trailing EPS of -$1.00,

Upcoming Q2
Earnings Date
Aug. 13Before Market OpensEstimated
Consensus EPS
(May. 12)
-$0.27
Actual EPS
(May. 12)
-$0.13 Beat By $0.14
Actual Revenue
(May. 12)
$4.58M

Q1 2026 Earnings Resources

PRLD Upcoming Earnings

Prelude Therapeutics' next earnings date is estimated for Thursday, August 13, 2026, based on past reporting schedules.

Get Prelude Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Prelude Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

PRLD Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PRLD Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Prelude Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20261-$0.27-$0.27-$0.27
Q2 20261-$0.23-$0.23-$0.23
Q3 20261-$0.22-$0.22-$0.22
Q4 20261-$0.22-$0.22-$0.22

Prelude Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/13/2026
(Estimated)
--------
5/12/2026Q1 2026-$0.27-$0.13+$0.14-$0.13$4.58M$4.58M
3/10/2026Q4 2025-$0.33-$0.20+$0.13-$0.20$20.50M$5.64M
11/12/2025Q3 2025-$0.35-$0.26+$0.09-$0.26-$6.50M
8/14/2025Q2 2025-$0.45-$0.41+$0.04-$0.41--
5/6/2025Q1 2025-$0.47-$0.42+$0.05-$0.42--
3/10/2025Q4 2024-$0.49-$0.38+$0.11-$0.38-$4.00M
11/6/2024--$0.48-$0.43+$0.05-$0.43-$3.00M
8/12/2024--$0.46-$0.46--$0.46--

Data powered by Fiscal.ai.


This page (NASDAQ:PRLD) was last updated on 5/26/2026 by MarketBeat.com Staff.
From Our Partners